Sponsored Lunch Symposium by Eisai

5 Aug 2022 12:00 13:00

Join Now

Assoc. Prof. Dr. Zamri Zuhdi Chairperson

Time	Session

12:00 13:00	The Possibility of Using Lenvatinib-based Therapy in Borderline Resectable/ Unresectable HCC Patients Dr. Hsueh Kuan Chun Speaker Tung's Metro Harbor Hospital